Abbott has introduced its new Proclaim DRG Neurostimulator System in the US for reducing pain in patients with complex regional pain syndrome (CRPS) of the lower limbs such as the foot, knee and hip.
With new patient-centric benefits, the magnetic resonance (MR) conditional system delivers stimulation to the dorsal root ganglion (DRG).
The device is recharge-free and upgradeable with enhanced battery capacity, while it uses the Apple iPod touch mobile digital device as its patient communication controller through a Bluetooth wireless technology.